View Latest Medical and Pharma Bids and Tenders

Open House Drug Discount Agreements Naproxen, Atc M01Ae02

Open House Drug Discount Agreements Naproxen, Atc M01Ae02

Medicines Containing The Active Ingredient Naproxen (Atc: M01Ae02)

Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Naproxen (Atc Code: M01Ae02).

Pharmaceutical Discount Agreements For Various Active Ingredients Within The Framework Of An Open-House Procedure

Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Naproxen (Atc Code: M01Ae02).

Medicines Containing The Active Ingredient Naproxen (Atc: M01Ae02)

Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Naproxen (M01Ae02) Within The Framework Of A So-Called Open-House Model.

Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Naproxen, Excluding The Syrup Dosage Form (Atc Code According To Who: M01Ae02)

Pharmaceutical Discount Contract From 01.10.2025 For The Combination Of Active Ingredients Naproxen & Esomeprazol As Part Of An Open House Procedure